Kent Meningitis Outbreak: Strain B Identified, Students Urged to Get Antibiotics

The recent deaths of a university student and a school pupil in Kent have been linked to an outbreak of meningitis caused by a strain of the disease – group B meningococcal – against which many young people are not vaccinated. Health officials are urging those who may have been exposed, particularly those who visited Club Chemistry in Canterbury between March 5th and 7th, to seek preventative antibiotic treatment.

Understanding the Outbreak and the Strain

Government scientists confirmed the outbreak in Kent is being driven by group B meningococcal disease, a serious bacterial infection that can lead to both meningitis (inflammation of the membranes surrounding the brain and spinal cord) and septicaemia (blood poisoning). Gayatri Amirthalingam, deputy director of immunisation and vaccine preventable diseases at the UK Health Security Agency (UKHSA), explained to BBC Radio 5 Live that testing has identified this specific strain as the cause. This is particularly concerning as routine vaccination programs do not currently cover group B for all age groups.

Currently, the UK’s routine vaccination schedule for teenagers typically includes a vaccine at ages 13 or 14 that protects against four main groups: A, C, W, and Y. As Amirthalingam noted, this leaves a gap in protection against group B, making preventative measures like antibiotic treatment crucial in controlling the current outbreak. The UKHSA is advising anyone who visited Club Chemistry in Canterbury on March 5th, 6th, or 7th to come forward for treatment as a “precautionary measure”. More clinics have been opened in Canterbury and Broadstairs to meet demand, following the distribution of around 1,300 doses of antibiotics yesterday.

How Meningitis Spreads and the Role of Close Contact

Meningococcal disease is spread through close contact. While the outbreak has prompted concern about potential transmission routes, including sharing vapes, health officials emphasize that multiple pathways exist. Eliza Gil, a clinical lecturer specialising in infectious disease at the London School of Hygiene & Tropical Medicine, highlighted that sharing anything involving mouth-to-mouth contact carries a risk of transmitting bacteria. “Sharing anything that goes in your mouth is a potential risk factor for transmitting a mouth-living bacteria,” she told BBC Radio 5 Live. “So for definite I would be not recommending vape sharing in general from a hygiene point of view.”

Though, it’s important to understand that vaping isn’t necessarily the sole cause. Amirthalingam clarified that the disease can spread through various activities involving close contact, and vaping is just one potential factor. The focus remains on identifying and treating those who may have been exposed, rather than pinpointing a single source of transmission.

Vaccination History and the Challenges of Group B Protection

The current situation raises questions about why a vaccine for group B isn’t more widely available. Gil explained the historical reasoning behind this decision. “Currently students aren’t offered it because the risk has historically been low and also because the protection is imperfect and not very long lived. So it was felt on balance of risk, that it wouldn’t be of benefit to students to routinely offer men B vaccination.”

Private vaccinations for meningitis B are available in the UK, costing between £100 and £120 per dose, with a full course of two doses ranging from £200 to £240. Boots currently offers a two-dose course for £220. However, the limited duration of protection offered by the vaccine is a key consideration in public health policy.

What the UKHSA is Doing and What Consider Do

The UKHSA has been working to quickly identify the links between cases and implement control measures. The agency has denied any delay in issuing alerts, stating they acted “very, very quickly” to respond to the outbreak. Two sites in Kent were already open for antibiotic distribution, with two more planned to open on Tuesday. The UKHSA is also monitoring the situation closely and will continue to provide updates as more information becomes available. Kent Online reports that Louise Jones-Roberts, the owner of Club Chemistry, estimates over 2,000 people visited the venue during the relevant dates.

If you are a university student or resident of Kent and visited Club Chemistry between March 5th and 7th, or if you are experiencing symptoms of meningitis – such as a high fever, severe headache, stiff neck, vomiting, or sensitivity to light – it is crucial to seek medical attention immediately. The UKHSA urges anyone offered antibiotics to take them promptly, as this is an effective measure for both self-protection and preventing further spread.

Ongoing Surveillance and Future Guidance

The current outbreak will likely prompt a review of meningitis surveillance and vaccination strategies. Public health officials continuously monitor disease patterns and adjust guidance based on emerging evidence. This includes assessing the effectiveness of current vaccination programs and considering whether changes are needed to address specific strains like group B. Further research may also be conducted to better understand the transmission dynamics of the disease and identify additional preventative measures. For the most up-to-date information and advice, refer to the UK Health Security Agency website and consult with a healthcare professional.

The situation serves as a reminder of the importance of vigilance and proactive public health measures in protecting against infectious diseases. While the current outbreak is concerning, the swift response from health officials and the availability of preventative treatment offer reassurance. Continued monitoring and adherence to public health guidance will be essential in containing the spread and safeguarding the health of the community. You can find more information about meningitis from the Meningitis Research Foundation.